The usefulness of arbekacin compared to vancomycin
The bacteriological efficacy response (improved, arbekacin vs. vancomycin; 71.2% vs. 79.5%) and clinical efficacy response (improved, arbekacin vs. vancomycin; 65.3% vs. 76.1%) were not statistically different between the two groups. The complication rate was significantly higher in the vancomycin g...
| Main Authors: | , , , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Springer-Verlag
2011
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3364417/ |